Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

Neuroscience Letters

Volumn 304, Issue 1-2, 2001, Pages 102-106

  Mehta, P D ^a   Pirttila, T ^b   Patrick, B A ^a   Barshatzky, M ^a   Mehta, S P ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

1 antichymotrypsin; Alzheimer disease; Amyloid protein; Apolipoprotein E; Enzyme linked immunosorbent assay

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CHYMOTRYPSIN A;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MENTAL HEALTH; PLASMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS;

EID: 0035907123     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01754-2     Document Type: Article

References (20)

1. Immunochemical identification of serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid
3. Platelets are the primary source of amyloid β-peptide in human blood
4. High cerebrospinal fluid tau and low amyloid beta 42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
5. Fate of cerebrospinal fluid-borne amyloid beta-peptide: Rapid clearance into blood and appreciable accumulation by cerebral arteries
6. Amyloid β protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms of Aβ40 and Aβ42(43)
7. Simplified isoelectric focusing/immunoblotting determination of apolipoprotein E phenotype
8. Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier
9. 1-Antichymotrypsin as a possible biochemical marker for Alzheimer type dementia
10. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease
11. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
12. Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease
13. 1-Antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease
14. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
15. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
16. Normal and abnormal biology of the β-amyloid
17. Amyloid β protein in plasma from patients with sporadic Alzheimer's disease
18. Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
19. Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease
20. Evidence that Aβ42 is the real culprit in Alzheimer's disease